
    
      All participants have to be able to read and understand the patient information sheet and
      sign the informed consent. All participants are free to stop being in the study whenever they
      wanted. The patients are not paid or reimbursed for participation.

      The study periods is 21 weeks during which the participant's have 8 appointments with the
      researchers. During the meetings research data will be collected and the participant is
      having Controlled Behavioral Therapy (CBT) consulting from a trained therapist. At the study
      visits, the subjects are given written instructions for the proper use of naltrexone and
      advised to take 50 mg naltrexone approximately one hour before gambling or feeling urges to
      gamble (and to refrain from taking naltrexone at other times). In this study the maximal
      daily dose is 50mg of naltrexone. The medication is free for the subjects.
    
  